Evidence map›Paper›PMID 24519066›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma.

Simi Santala, Anne Talvensaari-Mattila, Ylermi Soini, Maria Honkavuori-Toivola, Markku Santala

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.Journal of experimental & clinical cancer research : CR · 2016
    Article
  7. Review
  8. Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Simi SantalaDepartment of Obstetrics and Gynecology, Oulu University Hospital, P.O. Box 24, 90029, Oulu, Finland.
Anne Talvensaari-Mattila
Ylermi Soini
Maria Honkavuori-Toivola
Markku Santala
Oulu University Hospital · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclins are a group of proteins that act as activators to cyclin-dependent kinases and are required for normal cell cycle transitions. Cyclin A is involved in the transitions between G1 to S and G2 to M. Its deregulation has been linked to a number of neoplasms, including endometrial cancer. The prognostic significance of cyclin A expression seems to be cancer-specific, and current knowledge on its impact on survival of endometrial cancer is limited. This study aimed to investigate the effect of cyclin A expression on cancer-specific survival and its correlation with conventional prognostic factors in endometrioid adenocarcinoma. Biopsies obtained from 211 patients were immunohistochemically stained for cyclin A and differences in expression analyzed at the Oulu University Hospital. Patients were divided into two groups utilizing the ROC curve. Further survival analyses were carried out between these two groups. In this study, we show that cyclin A expression correlates with tumor grade and FIGO stage. We also show that cyclin A is an independent prognostic factor in endometrioid adenocarcinoma. Whether cyclin A plays a role in tumorigenesis or merely is a marker of increased proliferation requires further studies.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCarcinoma, EndometrioidCyclin AEndometrial NeoplasmsFemaleHumansImmunohistochemistryMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsCyclin A

Identifiers

PMID24519066
OpenAlexW1984974202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.